Miami, FL51 Active Studies

Myocardial Infarction Clinical Trials in Miami, FL

Find 51 actively recruiting myocardial infarction clinical trials in Miami, FL. Connect with local research sites and explore new treatment options.

51
Active Trials
47
Sponsors
36,518
Enrolling

Recruiting Myocardial Infarction Studies in Miami

About Myocardial Infarction Clinical Trials in Miami

Myocardial infarction (heart attack) occurs when blood flow to a part of the heart muscle is blocked, causing tissue damage. It requires emergency treatment to restore blood flow. Long-term management includes dual antiplatelet therapy, statins, beta-blockers, and cardiac rehabilitation.

There are currently 51 myocardial infarction clinical trials recruiting participants in Miami, FL. These studies are seeking a combined 36,518 participants. Research is being sponsored by Massachusetts General Hospital, Ohio State University Comprehensive Cancer Center, American Gastroenterological Association and 44 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myocardial Infarction Clinical Trials in Miami — FAQ

Are there myocardial infarction clinical trials in Miami?

Yes, there are 51 myocardial infarction clinical trials currently recruiting in Miami, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Miami?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Miami research site will contact you about next steps.

Are clinical trials in Miami free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Miami studies also compensate for your time and travel.

What myocardial infarction treatments are being tested?

The 51 active trials in Miami are testing new therapies including novel drugs, biologics, and treatment approaches for myocardial infarction.

Data updated October 20, 2026 from ClinicalTrials.gov